AI in the healthcare space has outpaced the rate of regulation, and without an update, HIPAA risks stifling innovation. The use of artificial intelligence (AI) and generative AI (GenAI) in the ...

Stryker has adjusted its 2025 profit outlook to between 9.5%-10%, up from 8.5%-9.5%, amid strong growth in its medical surgery and neurotechnology unit.

The FDA has approved SetPoint Medical’s neuroimmune modulation device, SetPoint System, to treat moderate-to-severe rheumatoid arthritis.

Natera has announced the initiation of the Phase II TEODOR trial of its Signatera test aimed at certain breast cancer patients.

RFK Jr's statewide tour promoting his Make America Healthy Again (MAHA) agenda has been called “performative” by a US health consultancy.

Following a period of relative dormancy, research and development in the Alzheimer’s disease space is booming. And mounting attention, both in the development of disease modifying therapies (DMTs) and ...

Axonius has acquired New York-headquartered healthcare cybersecurity firm Cynerio in a $100m cash and stock deal.

Precision temperature monitoring and advanced materials are key to ensuring effective outcomes for radiofrequency ablation ...

Johnson & Johnson MedTech has launched the VIRTUGUIDE System, an AI-powered Lapidus solution to minimise bunion surgery complexities.

Olympus and private equity firm Revival Healthcare Capital have co-founded a new endoluminal robotics startup named Swan EndoSurgical Robotics.

The advent of artificial intelligence (AI) at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices.

GE HealthCare and Ascension have partnered to improve clinical and operational outcomes within the latter’s national network.